QURE
QURE
NASDAQ · Biotechnology

Uniqure Nv

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$16.09
+0.83 (+5.44%)
As of Mar 22, 10:07 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 17 77%
Hold 5 23%
Sell 0 0%
Price Target
Analyst Price Target +8.8% upside
Low Target $11.65
Average Target $17.51
High Target $27.07
Current Price $16.09
Current
$16.09
Target
$17.51
$11.65 $17.51 avg $27.07
Scenario Analysis
Bear Case
$11.65
-27.6%
Low target
Base Case
$17.51
+8.8%
Avg target
Bull Case
$27.07
+68.2%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$71.50
-77.5% from high
52-Week Low
$7.76
+107.3% from low
Target vs 52W High
$17.51
-75.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%